ARS Pharmaceuticals Inc XNAS: SPRY

Expensive Underperformer

Download real time

7.32 -0.89 (-10.84%)

New 52W Low today

3.0M

XNAS Volume

XNAS 17 Nov, 2025 4:30 PM (EST)

ARS Pharmaceuticals Inc quarterly and annual earnings report: results, revenue, profit, P&L, balance sheet, cash flow, financial ratios, revenue mix, peer comparison, and financial documents